This video highlights quality-of-life results from a large prospective study of men treated for breast cancer.
In this video, Kathryn J. Ruddy, MD, MPH, of the Mayo Clinic in Rochester, Minnesota, discusses quality-of-life results from a large prospective study of men treated for breast cancer.
Results of the international study were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS), held December 5–9 in San Antonio, Texas.
Enobosarm Shows Activity, Tolerability in ER+/HER2– Advanced Breast Cancer
March 8th 2024Findings from a phase 2 trial support the premise that activating the androgen receptor may elicit antitumor effects in patients with androgen receptor–positive, estrogen receptor–positive, HER2-negative breast cancer.